A novel index for assessing treatment plan quality in stereotactic radiosurgery

J Neurosurg. 2018 Dec 1;129(Suppl1):118-124. doi: 10.3171/2018.7.GKS18694.

Abstract

OBJECTIVEStereotactic radiosurgery (SRS) is characterized by high levels of conformity and steep dose gradients from the periphery of the target to surrounding tissue. Clinical studies have backed up the importance of these factors through evidence of symptomatic complications. Available data suggest that there are threshold doses above which the risk of symptomatic radionecrosis increases with the volume irradiated. Therefore, radiosurgical treatment plans should be optimized by minimizing dose to the surrounding tissue while maximizing dose to the target volume. Several metrics have been proposed to quantify radiosurgical plan quality, but all present certain weaknesses. To overcome limitations of the currently used metrics, a novel metric is proposed, the efficiency index (η50%), which is based on the principle of calculating integral doses: η50% = integral doseTV/integral dosePIV50%.METHODSThe value of η50% can be easily calculated by dividing the integral dose (mean dose × volume) to the target volume (TV) by the integral dose to the volume of 50% of the prescription isodose (PIV50%). Alternatively, differential dose-volume histograms (DVHs) of the TV and PIV50% can be used. The resulting η50% value is effectively the proportion of energy within the PIV50% that falls into the target. This value has theoretical limits of 0 and 1, with 1 being perfect. The index combines conformity, gradient, and mean dose to the target into a single value. The value of η50% was retrospectively calculated for 100 clinical SRS plans.RESULTSThe value of η50% for the 100 clinical SRS plans ranged from 37.7% to 58.0% with a mean value of 49.0%. This study also showed that the same principles used for the calculation of η50% can be adapted to produce an index suitable for multiple-target plans (Gη12Gy). Furthermore, the authors present another adaptation of the index that may play a role in plan optimization by calculating and minimizing the proportion of energy delivered to surrounding organs at risk (OARη50%).CONCLUSIONSThe proposed efficiency index is a novel approach in quantifying plan quality by combining conformity, gradient, and mean dose into a single value. It quantifies the ratio of the dose "doing good" versus the dose "doing harm," and its adaptations can be used for multiple-target plan optimization and OAR sparing.

Keywords: AUC = area under the curve; CSF = cerebrospinal fluid; DVH = dose-volume histogram; GI = gradient index; Gη = global efficiency index; OAR = organ at risk; OARη50% = OAR efficiency index; PCI = Paddick conformity index; PIV = prescription isodose volume; PIV50% = volume of half the prescription isodose; PTV = planning target volume; SRS = stereotactic radiosurgery; TCP = tumor control probability; TV = target volume; conformity; gradient; index; plan quality; radiotherapy; stereotactic radiosurgery; η50% = efficiency index.

MeSH terms

  • Brain / diagnostic imaging
  • Brain / radiation effects
  • Cerebrospinal Fluid
  • Humans
  • Neuroma, Acoustic / diagnostic imaging
  • Neuroma, Acoustic / radiotherapy
  • Quality Assurance, Health Care / methods*
  • Radiosurgery* / methods
  • Radiotherapy Dosage
  • Radiotherapy Planning, Computer-Assisted
  • Retrospective Studies
  • Temporal Bone / diagnostic imaging
  • Temporal Bone / radiation effects